Viewing Study NCT00111020


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-01-29 @ 12:45 AM
Study NCT ID: NCT00111020
Status: COMPLETED
Last Update Posted: 2014-08-06
First Post: 2005-05-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Renal Cell View
Keywords: